Gene · 7472
Papers3,221
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,221
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAST as a Potential Oncogene, Identified by Machine Search, in Gastric Cancer Infiltrated with Macrophages and Associated with Lgr5. | Biomolecules | 2022 | 35625600 | PubTator, text mining | PubMed |
| Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy. | Antioxidants (Basel) | 2022 | 35624785 | PubTator, text mining | PubMed |
| Cardioprotective effects of sodium thiosulfate against doxorubicin-induced cardiotoxicity in male rats. | BMC Pharmacol Toxicol | 2022 | 35614478 | PubTator, text mining | PubMed |
| Extracellular vesicle biomarkers for pancreatic cancer diagnosis: a systematic review and meta-analysis. | BMC Cancer | 2022 | 35606727 | PubTator, text mining | PubMed |
| Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells. | Front Oncol | 2022 | 35600367 | PubTator, text mining | PubMed |
| Importance of Sclerostin as Bone-Muscle Mediator Crosstalk. | Ann Geriatr Med Res | 2022 | 35599457 | PubTator, text mining | PubMed |
| KMT2B promotes the growth of renal cell carcinoma via upregulation of SNHG12 expression and promotion of CEP55 transcription. | Cancer Cell Int | 2022 | 35597996 | PubTator, text mining | PubMed |
| The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers. | Integr Cancer Ther | 2022 | 35593403 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. | J Oncol | 2022 | 35586209 | PubTator, text mining | PubMed |
| Short and long-term effect of dexamethasone on the transcriptome profile of primary human trabecular meshwork cells in vitro. | Sci Rep | 2022 | 35585182 | PubTator, text mining | PubMed |
| Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale. | J Med Chem | 2022 | 35581674 | PubTator, text mining | PubMed |
| Ferritin Light Chain: A Candidate Autoantigen in Immuno-Related Pancytopenia. | Front Immunol | 2022 | 35572557 | PubTator, text mining | PubMed |
| De novo variants of CSNK2B cause a new intellectual disability-craniodigital syndrome by disrupting the canonical Wnt signaling pathway. | HGG Adv | 2022 | 35571680 | PubTator, text mining | PubMed |
| Long non-coding RNA LINC02613 is a prognostic biomarker for breast cancer and correlates with the cell cycle and immune infiltration based on TCGA data. | Transl Cancer Res | 2022 | 35571659 | PubTator, text mining | PubMed |
| The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. | Cancers (Basel) | 2022 | 35565231 | PubTator, text mining | PubMed |
| Tissue Niches Formed by Intestinal Mesenchymal Stromal Cells in Mucosal Homeostasis and Immunity. | Int J Mol Sci | 2022 | 35563571 | PubTator, text mining | PubMed |
| CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy. | Int J Mol Sci | 2022 | 35563270 | PubTator, text mining | PubMed |
| The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer. | Int J Mol Sci | 2022 | 35563163 | PubTator, text mining | PubMed |
| Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers. | Int J Mol Sci | 2022 | 35562979 | PubTator, text mining | PubMed |
| A New Player in Depression: MiRNAs as Modulators of Altered Synaptic Plasticity. | Int J Mol Sci | 2022 | 35562946 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7472/papers?page=36